✦ LIBER ✦

Weekly Paclitaxel and Carboplatin against Advanced Transitional Cell Cancer after Failure of a Platinum-Based Regimen

✍ Scribed by Tsutomu Kouno; Masashi Ando; Kan Yonemori; Koji Matsumoto; Chikako Shimizu; Noriyuki Katsumata; Motokiyo Komiyama; Eijiro Okajima; Naoki Matsuoka; Hiroyuki Fujimoto; Yasuhiro Fujiwara

Book ID: 113610016
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 248 KB
Volume: 52
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.03.078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial Comment on: Weekly Paclitaxel

Editorial Comment on: Weekly Paclitaxel and Carboplatin against Advanced Transitional Cell Cancer after Failure of a Platinum-Based Regimen

✍ Hans von der Maase 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Phase II Trial of Weekly Paclitaxel and

Phase II Trial of Weekly Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Transitional Cell Cancer

✍ Manfred Johannsen; Markus Sachs; Jan Roigas; Axel Hinke; Andrea Staack; Stefan A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Epirubicin and paclitaxel (EPI-TAX regim

Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens

✍ Isabelle Ray-Coquard; Thomas Bachelot; Jean-Paul Guastalla; Éric Levy; Jean-Domi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Interim analysis of a phase II study of

Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancer

✍ Chandra P Belani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 283 KB

699 Phase II trial of paclitaxel and car

699 Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer

✍ M. Johannsen; A. Wille; J. Roigas; D. Schnorr; S. Loening 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 210 KB

A carboplatin-based regimen for the trea

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium

✍ Eric J. Small; Linda J. Fippin; Mary Lou Ernest; Peter R. Carroll 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

## EIACKGROUND. Many patients with advanced transitional cell carcinoma are unable to receive cisplatin-based therapy. The efficacy and toxicity of a carboplatin-based regimen in the treatment of patients with advanced transitional cell carcinoma was therefore evaluated. ## METHODS. Twenty-thre